NCT04516577View on ClinicalTrials.gov

Updated Severity and Prognosis Score of Pulmonary Alveolar Proteinosis

CompletedOBSERVATIONAL
Enrollment

231

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Pulmonary Alveolar Proteinosis
Interventions
OTHER

Assesssing the severity of pulmonary alveolar proteinosis

Three severity scores will be used to assess the severity of patients with pulmonary alveolar proteinosis.

Trial Locations (1)

200433

Shanghai pulmonary hospital, Shanghai

All Listed Sponsors
lead

Shanghai Pulmonary Hospital, Shanghai, China

OTHER

NCT04516577 - Updated Severity and Prognosis Score of Pulmonary Alveolar Proteinosis | Biotech Hunter | Biotech Hunter